Protein aggregation that results in the formation of inclusions is strongly correlated with 17 neuronal death and is a pathological hallmark common to many neurodegenerative diseases, 18
Introduction 40
The formation of intracellular protein inclusions is a characteristic hallmark of 41 neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), Parkinson's 42 disease (PD) and Huntington's disease (HD) (Chiti and Dobson 2017) . In these diseases, 43
proteins are either intrinsically disordered or partially unfold and self-associate through 44 hydrophobic interactions between regions that are usually buried in the native conformation 45 (Hipp, Kasturi et al. 2019 ). These inappropriate interactions nucleate the formation of protein 46 aggregates that are the building blocks of protein inclusions (Kopito 2000) . Inclusion formation 47 has been strongly correlated with the death of neurons in neurodegenerative diseases (Braak, which are well-characterised molecular chaperones capable of stabilising and re-folding 69 misfolded proteins, with additional functions in trafficking damaged proteins to proteasomal or 70 autophagy-lysosome degradation pathways (Leak 2014) . Heat shock proteins have previously 71 been shown to interact with disease-associated mature aggregates in vitro (Cox, Whiten et prone, acetylation-mimicking mutant of ALS-associated TAR DNA-binding protein-43 (TDP-83 43) (Wang, Wander et al. 2017) . Likewise, over-expression of HSF1 in a mutant superoxide 84 dismutase-1 (SOD1) mouse model of ALS, led to a 34% decrease in the level of insoluble 85 SOD1 H46R/H48Q in spinal cord tissue compared to controls (Lin, Simon et al. 2013 ). The over-86 expression of constitutively active HSF1 in the R6/2 mouse model of HD led to a 79% 87 reduction in the proportion of nuclei with inclusions and extended survival by 16 days (mean 88 survival 122 days in R6/2-HSF1Tg compared to 102 days in R6/2 mice) (Fujimoto, Takaki et 89 al. 2005) . Therefore, activating the HSR and over-expressing Hsps in the CNS has promising 90 therapeutic potential to ameliorate protein aggregation and extend survival in 91 neurodegenerative diseases. 92
The activation of HSF1 may be differentially stimulated by misfolded proteins depending on 93 whether they are sequestered into iPODs (Insoluble PrOtein Deposits), JUNQ (JUxtaNuclear 94 Quality control), or other undefined sub-types of protein inclusions (Kaganovich, Kopito et al. 95 2008) . There is compelling evidence to suggest that HD-associated poly-glutamine expanded 96 huntingtin is sequestered into iPODs, immobile inclusions for the storage of terminally 97 aggregated proteins, that have little interaction with the proteostasis network (Kayatekin, 98 Matlack et al. 2014, Polling, Mok et al. 2014) . In contrast, it has been demonstrated that mutant 99 SOD1 is partitioned into JUNQ compartments in which proteins are able to diffuse and are 100 ubiquitinated, indicating a role for the ubiquitin-proteasome system (Matsumoto, Kim et al. 101 2006, Polling, Mok et al. 2014 , Farrawell, Lambert-Smith et al. 2015 . In addition to the sub-102 type of inclusion formed, the propensity of different neurodegenerative disease-associated 103 proteins to undertake different off-folding pathways, i.e. amorphous or amyloid aggregation, 104 may represent another factor that determines whether an HSR is induced. 105
The anti-aggregation and cytoprotective benefits of Hsps in cells cannot be realised if an HSR 106 is not induced in neurons and glia in response to protein aggregation in neurodegenerative 107 disease. The existence of intracellular inclusions and the cell-to-cell spread of aggregated 108 proteins in neurodegenerative diseases led us to hypothesise that cells are not able to respond 109 to protein aggregation by inducing the HSR. To evaluate this, we generated a stable cell line 110 derived from mouse neuroblastoma, Neuro-2a, that express a fluorescent reporter under the 111 control of a truncated Hspa1a promoter comprised of 8 putative HSEs. We then used this 112 stable cell line to quantitatively assess the kinetics and magnitude of HSR induction after 113 exogenous application of protein aggregates and intracellular inclusion formation. Moreover, 114
we dissected the role of inclusion size, rate of formation, and intracellular protein concentration 115 on HSR induction using these cells. We identified that whilst cells were able to activate the 116 HSR in response to aggregation-prone non-pathogenic proteins, they failed to mount a 117 significant HSR in response to the exogenous application or intracellular expression of 118 pathogenic proteins. In addition, the intracellular levels of all aggregation-prone proteins tested 119 was the most significant determinant of HSR induction and demonstrated a positive correlation 120 between protein concentration and proportion of cells with an activated HSR. The relatively 121 poor induction of the HSR by pathogenic compared to non-pathogenic proteins could explain, 122 at least in part, the ability of aggregates to evade molecular chaperones, form protein 123 inclusions, and subsequently spread to other regions of the CNS in the context of 124 neurodegenerative diseases. 125 (R188Q/R261Q) form of Fluc (Fluc DM ) were also generated. To do so, the cerulean gene was 146 PCR amplified from pT-Rex-Htt 72Q using forward: 5′-catggatccaccggtcgccaccatggtgagca-3′ 147 and reverse: 5′-caggattcttacttgtacagctc-3′ primers with flanking BamHI/BsrGI restriction sites 148 to replace the EGFP gene in pEGFP-N1-SOD1 WT and pEGFP-N1-SOD1 G93A . The cerulean 149 gene was PCR amplified from pT-Rex-Htt 72Q using forward 5′-150 catgggatccaccggccggtcgccaccatggtgagc-3′ and reverse: 5′-caggattcttacttgtacagctc-3′ primers 151 with flanking BamHI/BsrGI restriction sites to replace the EGFP gene in pcDNA4-TO-myc-152
hisA-EGFP-Fluc WT and pcDNA4-TO-myc-hisA-EGFP-Fluc DM (these constructs were kind gifts 153 of Prof Mark Wilson, University of Wollongong, NSW, Australia). All the constructs generated 154 and used in this work were verified by sequencing using a Hitachi 3130xl Genetic Analyser 155 (Applied Biosystems, MA, USA). 156
Generation of SOD1 G93A and α-synuclein aggregates 157
Thioflavin T-based aggregation assays 158
The formation of SOD1 G93A aggregates was monitored by an in situ thioflavin T (ThT) binding 159 assay that has previously been described ( Branson Ultrasonics, CT, USA), using 30% amplification and 3 cycles of 10 s pulses. The 173 fibrils were flash frozen in liquid nitrogen and stored at -80°C until required. To produce mature 174 fibrils, 100 µM of monomeric α-synuclein was incubated with 1% (w/w) α-synuclein seeds in 175 50 mM phosphate buffer (pH 7.4) at 37°C for 72 h. A 5 µL aliquot of the α-synuclein fibrils was 176 then loaded into a black clear-bottomed 384-well plate with 25 µL 50 mM phosphate buffer 177 containing 10 µM ThT. The ThT fluorescence was measured by excitation at 450 nm and its 178 emission read at 480 nm using the bottom optic. 179
Transmission electron microscopy of SOD1 G93A and α-synuclein 180
Transmission electron microscopy (TEM) was employed to visualise the recombinant 181 SOD1 G93A and α-synuclein aggregates. An 8 µL aliquot of the aggregated protein was applied 182 onto an ultrathin carbon film coated 400 mesh copper TEM grid (ProSciTech, QLD, Australia). 183
Samples were then diluted with 2 µL of 0.22 µm filtered milli-Q H2O and left for 3 min. Grids 184 were dried with lint-free paper by wicking away the H2O from the side. Grids were washed with 185 10 µL of milli-Q H2O, dried again, and 10 µL of 1% (w/v) phosphotungstic acid, the contrast 186 reagent, was added and grids left to incubate for 1 min. The phosphotungstic acid was wicked 187 away and the grids were washed twice with 10 µL of milli-Q H2O. Grids were air dried and 188 imaged at the Australian Institute of Innovative Materials (University of Wollongong) using a 189 JEM-2011 TEM (JEOL, Japan). Images were processed using Digital Micrograph (Gatan, CA, 190 USA). 191
Cell culture of Neuro-2a 192
The murine neuroblastoma cell line, Neuro-2a, was obtained from the American Type Culture 193
Collection (VA, USA). All cell lines were cultured in DMEM/F-12 supplemented with 2.5 mM 194
L-glutamine and 10% (v/v) FCS (10% FCS-DMEM/F-12) at 37°C under 5% CO2/95% air in a 195
Heracell 150i CO2 incubator (Thermo Fisher Scientific). Cells were passaged every 2 days or 196 once they had reached 80% confluency. The cells were tested for mycoplasma on receipt of 197 the cell line and quarterly thereafter using the MycoAlert Mycoplasma Detection Kit according 198 to the manufacturer's instructions (Lonza, Basel, Switzerland). 199
Generation and maintenance of Neuro-2a stable cells 200
Stable cell lines for the constitutive expression of mCherry and stress-inducible expression of 201 EGFP were generated in Neuro-2a cells. Thus, activation of the HSR (i.e. HSF1 binding to 202 HSEs) after treatment with a stressor could be monitored in cells in real time using EGFP as 203 a fluorescent reporter. Neuro-2a cells were used because they have a neuronal origin and 204 high transfection and co-transfection efficiencies using standard lipid-based protocols. To obtain a polyclonal Neuro-2a cell population with stress-inducible EGFP expression, cells 213 were heat shocked (42°C for 2 h with recovery at 37°C for 6 h), harvested by trypsinisation 214 with 0.25% (w/v) trypsin-EDTA at 37°C for 5 min, washed twice in PBS, and resuspended in 215 FACS buffer, 1 mM EDTA, 25 mM HEPES and 0.5% (w/v) BSA in PBS. These cells were then 216 sorted using an S3e Cell Sorter (Bio-Rad Laboratories, NSW, Australia) equipped with 488 217 nm and 561 nm lasers. Viable, single cells were resolved based on plots of forward scatter-218 area versus side scatter-area and forward scatter-area versus forward scatter-height. 219
Subsequently, mCherry +ve /EGFP +ve cells were identified and sorted and maintained in 220 complete medium supplemented with 1 ´ penicillin/streptomycin to prevent bacterial 221 contamination. These EGFP HSR reporter cell lines are referred to in this work as Neuro-2a 222 (HSE:EGFP), given EGFP expression is driven by HSF1 binding to HSEs. Neuro-2a (HSE:EGFP) with 300 µg/mL G418 and 100 µg/mL hygromycin. 226
Cell stress treatments 227

Heat shock, cadmium chloride (CdCl2), and celastrol treatment assays 228
Heat shock, CdCl2 and celastrol (AdooQ Biosciences, CA, USA) were used to assess the 229 capacity of Neuro-2a cells to induce an HSR. Neuro-2a (HSE:EGFP) cells were seeded at a 230 density of 200,000 cells/mL into 12-well plates. Optimal concentrations of CdCl2 and celastrol 231 were determined in concentration-response assays, whereby cells were either treated with 232
CdCl2 (0-33 µM) or celastrol (0 -1 µM) for 24 h. In addition, cells were heat shocked (42°C 233 for 2 h) and allowed to recover for different times at 37°C. After each treatment, Neuro-2a 234 (HSE:EGFP) cells were imaged every 2 h for 24 h using an IncuCyte Live Cell Analysis System 235 (Essen BioScience, MI, USA). The optimal treatment concentrations and times for induction 236 of an HSR in these cells were determined to be 10 µM for 24 h for CdCl2, 0.75 µM for 24 h for 237 celastrol and heat shock at 42°C for 2 h with recovery at 37°C for 24 h. 238
As a means of assessing magnitude and kinetics of HSR induction following each treatment, 239 the maximum EGFP fluorescence intensity and time taken to reach half of the EGFP maximum 240 intensity was analysed. 241
Extracellular aggregation stress assays 242
Pathogenic protein aggregates were applied extracellularly to Neuro-2a (HSE:EGFP) cells 243 and activation of the HSR was assessed. Prior to treatment, soluble non-aggregated α-244 synuclein and SOD1 G93A were centrifuged (14,000 × g for 30 min at 4°C) to remove any 245 oligomeric seeds that may have spontaneously formed. Aggregated SOD1 G93A was pelleted 246 (14,000 × g for 30 min at 4°C) and resuspended in fresh PBS to eliminate possible cytotoxicity 247 of DTT and EDTA in the assay. 248
Neuro-2a (HSE:EGFP) cells were seeded at a density of 100,000 cells/mL in a 96-well plate 249 and cultured overnight in 10% FCS DMEM/F12. The following day, media was refreshed with 250 serum free DMEM/F12 and cells were either treated with buffer alone (50 mM phosphate 251 buffer for α-synuclein or PBS for SOD1 G93A ), monomeric α-synuclein or aggregated α-252 synuclein (1 µM and 10 µM), or dimeric SOD1 G93A or aggregated SOD1 G93A (1 µM and 10 µM) 253 diluted in serum-free DMEM/F12. Three wells in each plate were treated with 10 µM CdCl2 as 254 a positive control for HSR induction. Cells were imaged every 2 h for 72 h in an IncuCyte Live 255
Cell Analysis System (Essen BioScience). 256
Intracellular protein aggregation stress assays 257
Neuro-2a (HSE:EGFP) cells were transfected with Cerulean-tagged WT and aggregation-258 prone mutant proteins. Cells were seeded at a density of 100,000 cells/mL in 12-well plates 259 and cultured in 1 mL of 10% FCS DMEM/F12 media overnight. Cells were transfected with 260 DNA:lipid complexes (1 µg DNA, 1 µL PLUS reagent, and 3 µL Lipofectamine LTX per well) 261 for the expression of Cerulean-tagged SOD1 WT , SOD1 G93A , Htt 25Q , Htt 72Q , Fluc WT , or Fluc DM . 262
As controls, parental Neuro-2a were either untransfected, or singly transfected to express 263 EGFP, mCherry or Cerulean fluorescent proteins. These samples were used to set gates for 264 the flow cytometric analysis and to determine the spectral overlap that occurs between these 265 three fluorophores so that spectral compensation could be applied prior to analysis. All 266 analyses of the flow cytometry data were performed using FlowJo (version 10.0.8, Tree Star, 267 OR, USA). 268
IncuCyte Zoom imaging and image analysis 269
Image analysis of total image fluorescence intensity 270
Time-lapse fluorescence intensity data from Neuro-2a (HSE:EGFP) cells were acquired using 271
an IncuCyte Live Cell Analysis System. Phase contrast and fluorescent images were acquired 272 at 2 h intervals with the 10× or 20× objective. The fluorescence intensity of mCherry and 273 stress-inducible EGFP were quantified using the basic analyser algorithm (Table 1) 
The mean EGFP relative fluorescence intensity (RFU) was normalised by dividing the EGFP 281 RFU by the mCherry RFU at each time point to account for relative changes in cell density 
Image analysis of single cell fluorescent intensities 289
Neuro-2a (HSE:EGFP) were either left untransfected or transfected to express Htt 72Q or Fluc DM 290 in an 8-well Ibidi chamber, and imaged on a Leica SP5 confocal microscope at 37˚C under 291 5% CO2/ 95% air. High-resolution images were captured using a 63 ´ water immersion 292 objective and widefield images were captured using a 40 ´ air objective (see Supplementary 293 2018). The mask parameters used for the identification of "cells" and "inclusions" are outlined 297
in Table 2 . These parameters were optimised to separate cell clumps and identify individual 298 cells and inclusions. Using these parameters, the following custom-made sequence of image 299 processing events was used to analyse all images in a non-biased manner; (i) all images were 300 converted to greyscale, (ii) "cells" were identified as primary objects (Table 2) , (iii) "inclusions" 301 were identified as primary objects (Table 2) , (iv) the region of the cell cytoplasm excluding the 302 inclusions was defined as "cells -inclusions" tertiary objects, (v) the Cerulean fluorescence 303
intensities of "cells" and EGFP fluorescence intensities of the regions defined as "cells -304
inclusions" was measured. The tertiary objects identified, "cells -inclusions", were applied to 305 eliminate the spectral overlap of the Cerulean fluorescence signal at the site of inclusions into 306 the EGFP fluorescence signal. In this way EGFP fluorescence was measured from an area of 307 the cell that did not contain inclusion bodies (i.e. "cells -inclusions"). 308 
311
Bivariate plots of the Cerulean and EGFP fluorescence intensities derived from regions 312 defined as "cells -inclusions" demonstrated a strong correlation suggesting that the Cerulean 313 signal was still contributing to the EGFP signal ( Supplementary Figure 4c ). This spectral 314 overlap was calculated to be 13% based on EGFP-and Cerulean-only controls. Therefore, 315 spectral compensation was performed on the EGFP data according to equation 3. (Figure 1d ). However, there were no 391 differences observed between the magnitude of HSR induction between treatment type in 392
Neuro-2a (HSE:EGFP) cells as determined by the fold change in fluorescence intensity at 24 393 h (Figure 1d ). Beyond the 24 h time-frame of these experiments, cells treated with CdCl2 or 394 celastrol died as a consequence of the toxicity of these treatments. Heat shocked cells 395 continued to grow and divide during the recovery period; EGFP fluorescence intensity peaked 396 at 10 h. 397 
411
Extracellular protein aggregates do not induce an HSR 412
There is increasing evidence that disease-associated protein aggregation propagates through 413 the CNS from the site of onset in a prion-like mechanism. This process likely involves the 414 release of misfolded and aggregated protein from neurons into the extracellular space and HSR. To test this, recombinant human α-synuclein and SOD1 G93A were aggregated in vitro. 419
There was a significant increase in ThT fluorescence of the aggregated α-synuclein sample 420 compared to monomeric α-synuclein and buffer alone, indicative of an increase in β-sheet 421 structure with aggregation (Figure 2a ). Transmission electron microscopy (TEM) indicated that 422 the α-synuclein had formed long, mature fibrils > 2 µm in length (Figure 2a inset). The 423 formation of SOD1 G93A aggregates was monitored by an in situ ThT binding assay; there was 424 a time-dependent increase in ThT fluorescence relative to buffer alone (Figure 2b) . The 425 SOD1 G93A aggregates formed in these assays had an irregular amorphous structure and were 426 < 80 nm in length (Figure 2b inset) . Together, the ThT and TEM data indicate that the 427 SOD1 G93A aggregates formed in this study contain an underlying β-sheet structure, but did not 428 assemble into highly-ordered fibrils. 429
Non-aggregated and aggregated forms of α-synuclein and SOD1 G93A were applied to Neuro-430 2a (HSE:EGFP) and the cells monitored for HSR induction by time-lapse live-cell imaging 431
( Figure 2c-f ). There was no significant difference in EGFP fluorescence in cells treated for 20 432 h with either 1 µM or 10 µM of non-aggregated or aggregated α-synuclein or SOD1 G93A ( Figure  433 2e-f), and this remained the case even up to 72 h after treatment (data not shown). In contrast, 434 the positive control CdCl2 treatment induced an HSR in these cells (Figure 2e-f ). Thus, these 435 extracellular aggregates of α-synuclein and SOD1 G93A associated with neurodegenerative 436 disease were not sufficient to induce an HSR in these cells. 437 Differences between the means were assessed using a one-way ANOVA followed by Dunnet's 447 post-hoc test (comparing to buffer alone control), where P < 0.001 (***). 448 449 450
Intracellular aggregation of pathogenic proteins is a poor inducer of the HSR 451
We next investigated whether the aggregation of proteins into inclusions in cells leads to the 452 induction of an HSR in Neuro-2a (HSE:EGFP) cells. To examine this, a suite of constructs 453 was generated for the expression of Cerulean-tagged SOD1 WT , SOD1 G93A , Htt 25Q , Htt 72Q , 454
Fluc WT , or Fluc DM . These proteins were selected because they represent a mix of (i) pathogenic 455 (SOD1 and Htt) and non-pathogenic (Fluc) aggregation-prone proteins and their WT isoforms, 456
(ii) JUNQ-, iPOD-, and "other" inclusion forming proteins (SOD1, Htt, Fluc, respectively), and 457 (iii) amyloidogenic (SOD1 and Htt) and amorphous (Fluc) proteins. 458
The propensity of each of these Cerulean-tagged proteins to aggregate was assessed by 459
FloIT, a flow cytometric method for the quantification of inclusions (Whiten, San Gil et al. (Figure 3c ). Cerulean-tagged SOD1 G93A formed inclusions, 464 which could be quantified (Figure 3d-e ). The total number of inclusions formed by each over-465 expressed protein varied and was highest for Fluc WT and Fluc DM . Differences between the 466 means were determined using a one-way ANOVA followed by Tukey's post-hoc test and there 467 were no statistically significant differences in the number of aggregates quantified in each 468
sample. 469
One factor that could possibly influence HSR induction is the size and granularity of the 470 inclusions formed by each protein, since this would be an indirect measure of the surface area 471 available to interact with cytoplasmic proteins. FloIT analysis demonstrated that the SOD1 WT 472 and Htt 25Q aggregates detected had a significantly greater granularity (SSC) compared to the 473 other proteins tested (P <0.01). In addition, the relative size of the inclusions formed by Htt 72Q 474
were significantly larger (based on the forward scatter, FSC, signal, Figure 3f Figure 4c . Expression of 501 the two pathogenic proteins, SOD1 G93A or Htt 72Q , resulted in 1.6 ± 0.4% and 4.0 ± 1.1% of the 502 transfected cells becoming EGFP +ve , respectively (Figure 4d and Supplementary Figure 3) . 503
However, this was not significantly different than the proportion of EGFP +ve cells expressing 504 non-aggregation prone isoforms of these proteins, i.e. SOD1 WT or Htt 25Q . In contrast, the 505 expression of Fluc DM resulted in HSR induction in 12.3 ± 1.3% of transfected cells, which was 506 significantly greater than HSR induction in cells expressing the aggregation-prone disease-507 related proteins (Figure 4c-d) . express Cerulean tagged SOD1 WT , SOD1 G93A , Htt 25Q , Htt 72Q , Fluc WT or Fluc DM proteins. After 512 48 h incubation, cells were harvested for analysis by flow cytometry. Cellular debris, cell 513 clumps, doublet events and untransfected cells were excluded from the analysis as described 514
in Supplementary Figure 2 . are the mean ± S.E.M. of three independent repeats. Statistically significant differences 519 between the means were determined by one-way ANOVA and Tukey's multiple comparisons 520 test, where P < 0.001 (***). 521
Given that the analysis of the entire cell population demonstrated that pathogenic SOD1 and 522
Htt did not elicit a significant HSR compared to their respective WT proteins, we next sought 523 to determine whether the expression level of an aggregation-prone protein affects the 524 induction of the HSR in these cells. To do so, events from the flow cytometric analyses were 525 binned according to the levels of Cerulean expression (5000 RFU per bin, where bin 1 526 contains cells with the lowest expression and bin 10 the highest level of expression; Figure  527 5a). For cells in each of these bins the proportion of cells in which an HSR was induced was 528
determined. Representative bivariate plots of EGFP and FSC of cells transfected to express 529
Htt 72Q in Cerulean bins 5 and 10 are shown in Figure 5b . By binning the flow cytometry data 530 in this way two factors can be assessed: (i) the effect of high and low protein concentration on 531 induction of the HSR, and (ii) the induction of the HSR in cells expressing WT and mutant 532 aggregation-prone proteins (Figure 5c-e) . 533
In SOD1 G93A -Cerulean expressing cells, as the amount of SOD1 G93A expressed by cells 534 increased so did the proportion of cells in which an HSR had been induced (0.4 ± 0.2% of 535 cells were EGFP +ve in bin 1 compared to 38.7 ± 7.3% of cells in bin 10; Figure 5c ). This same 536 trend was observed for cells expressing Htt 72Q , Fluc WT and Fluc DM , i.e. cells expressing the 537 highest amounts of these proteins (bin 10) had the highest proportion of EGFP +ve cells (23.4 538 ± 7.6%, 37.1 ± 15.9%, and 57.7 ± 10%, respectively; Figure 5d -e). In contrast, over-expression 539 of non-aggregation prone isoforms of SOD1 WT and Htt 25Q did not induce an HSR in any 540 cerulean bin demonstrating that it is not simply protein over-expression that induces an HSR. 541
The HSR was most sensitive to increasing concentrations of Fluc DM and Fluc WT , for example 542 in Cerulean bins 1 and 2, respectively, an EGFP +ve population was already evident. 543
Comparatively, there is a significant increase in the proportion of EGFP +ve cells in bin 5 and 544 bin 4 for Htt 72Q and SOD1 G93A , respectively, compared to WT controls. Together, these data 545
show that an HSR is activated at lower relative levels of expression of Fluc WT and Fluc DM 546 compared to Htt 72Q and SOD G93A . 547 repeats. Differences between the means were determined using a two-way ANOVA followed 557
by Bonferroni's post hoc test, where P < 0.05 (*) and P < 0.01 (**). 558 559
Formation of inclusions precedes the detection of HSR induction 560
Finally, we sought investigate whether HSR activation occurs before or after inclusion 561 formation in cells to determine whether the HSR induction we observe is in response to protein 562 aggregation. We used Neuro-2a (HSE:EGFP) cells over-expressing Htt 72Q or Fluc DM for these 563 experiments as both readily form inclusions yet have a differential capacity to induce an HSR 564 ( Figure 3e and Figure 4d ). This is exemplified by the proportion of EGFP +ve events in cells 565
expressing Htt 72Q (4.0 ± 1.1%) compared to Fluc DM (12.3 ± 1.3%; Figure 4d ). Live-cell time-566 lapse confocal imaging of Neuro-2a (HSE:EGFP) cells facilitated the simultaneous tracking of 567 Htt 72Q or Fluc DM expression, inclusion formation, and HSR induction in single cells ( Figure 6) . 568
There was no detectable HSR induction observed at any time point following transfection of 569 cells with Htt 72Q (Figure 6 ). However, in cells expressing Fluc DM , there was an increase in 570 EGFP expression, indicative of HSR induction, in 2 of the 3 representative cells depicted in 571 Images are representative of three independent experiments. 581
We used a non-biased image quantification strategy to analyse wide-field of view images of 582 treated or transfected cells over time to assess the proportion of HSR-positive cells. Due to 583 the broad fluorescence emission spectrum of the Cerulean protein, spectral overlap was 584 observed between the channels used to detect EGFP and Cerulean fluorescence, particularly 585 in regions containing inclusions ( Supplementary Figure 4a) . To minimise spectral overlap, 586 narrow emission windows for detection of Cerulean and EGFP fluorescence were used when 587 imaging (462-492 nm and 506-563 nm, respectively; Supplementary Figure 4a ). Despite this, 588 an apparent EGFP signal was observed in areas containing inclusions comprised of Cerulean-589 tagged proteins (areas of intense fluorescence; Supplementary Figure 4a (Figure 7b ). In contrast, there was no or low effect of Htt 72Q expression on 604 the proportion of EGFP +ve cells over time, which indicates the relative lack of HSR induction in 605 these cells (Figure 7b ). There was a significantly greater proportion of EGFP +ve cells in 606 samples expressing Fluc DM compared to Htt 72Q [F (1, 144) = 33.43, P < 0.0001]. Post-hoc 607 analysis using Bonferroni's test showed that this difference was statistically significant 21 h 608 following transfection. Therefore, Fluc DM and Htt 72Q have differential capacities to induce the 609
HSR. 610
To determine whether this difference in HSR induction was associated with the aggregation 611 rate of Fluc DM compared to Htt 72Q , the proportion of cells with Htt 72Q or Fluc DM inclusions was 612 determined over the time-course of the live-cell imaging experiment (Figure 7c ). There was a 613 The HSR is widely recognised as a first line of defence against protein aggregation. However, 644
an explanation as to why Hsps fail to suppress the formation of protein aggregates in 645 neurodegenerative diseases is lacking. Therefore, we investigated whether inclusions are 646 capable of inducing an HSR in a cell-line of neuronal origin. In this work, we provide strong 647 evidence that extracellular and intracellular disease-associated protein aggregates are poor 648 inducers of the HSR. Namely, using Neuro-2a (HSE:EGFP) cells, we showed that the 649 extracellular application of pathogenic aggregates (a-synuclein and SOD1 G93A ) does not 650 induce an HSR. Over-expression of pathogenic proteins, Htt 72Q and SOD1 G93A , induced an 651 HSR in a small but not significant proportion of cells, whereas the expression of the non-652 disease related Fluc DM induced an HSR in a significantly greater proportion of cells compared 653 to SOD1 G93A and Htt 72Q . Moreover, we established that there is a positive relationship between 654 the concentration of aggregation-prone proteins and induction of the HSR in cells, indicating 655 that relatively higher intracellular concentrations of aggregation-prone proteins correlate with 656 HSR induction. Our study provides evidence that disease-associated protein aggregates have 657 limited capacity to induce an HSR. Therapeutic strategies that activate the HSR in order to 658 enhance levels of molecular chaperones, such as the Hsps, and restore proteostasis may 659 therefore be of benefit in these disorders. 660
The cell-to-cell transfer of protein aggregates through the extracellular medium is thought to 661 be one mechanism by which neurodegenerative diseases progress from a focal point of onset 662 Taken together, these findings suggest a possible common underlying mechanism in 704 neurodegenerative diseases, whereby disease-associated proteins evade or attenuate the 705 HSR, which facilitates inclusion formation and propagation throughout the CNS. Future 706 research that incorporates a range of wild-type and disease-causing, aggregation-prone 707 proteins could establish whether this is a molecular pathology common to all 708 neurodegenerative diseases. 709
We hypothesised that the rate of protein aggregation or the surface area of the inclusion 710 exposed to the cytosol would play a significant role in inducing the HSR. Therefore, flow 711 cytometry and live cell confocal imaging experiments were performed to assess whether the 712 capacity of cells to induce an HSR could be attributed to: (i) the rate of inclusion formation of 713 the protein, (ii) the physical properties of the inclusions formed (i.e. size and granularity), 714 and/or (iii) the intracellular concentration of the aggregation-prone protein. To our knowledge, 715 this is the first study to report on the effects of aggregate size and rate of aggregate formation 716 on the induction of the HSR. Since cells expressing Htt 72Q exhibited lower HSR induction 717 compared to Fluc DM , we hypothesised that the rate of inclusion formation could be a key 718 determinant in induction of the HSR. Interestingly, there was no significant difference in the 719 rate at which Htt 72Q inclusions that were significantly smaller than those formed by Htt 72Q but were similar in size 728 those formed by SOD1 G93A . Since SOD1 G93A only induced an HSR in a low proportion of cells, 729 these findings indicate that the size and granularity of the aggregate does not influence 730 induction of the HSR in these cells. 731
High intracellular levels of proteins that exceed their predicted solubility is a key determinant 732 of protein aggregation. This "supersaturation" concept is thought to be a significant factor 733 driving protein aggregation in neurodegenerative diseases (Ciryam, Kundra et al. 2015) . we determined whether increasing concentrations of aggregation-prone proteins (and thus 741 their level of saturation) resulted in induction of the HSR. Our data show that there is a strong 742 positive correlation between the amount of the aggregation-prone protein in cells (SOD1 G93A , 743
Htt 72Q , Fluc DM and Fluc WT ) and HSR induction. Significantly, this correlation was not observed 744 for non-pathogenic forms of these disease-related proteins which are much less prone to 745 aggregation (SOD1 WT and Htt 25Q ). Thus, the levels of these proteins per se does not drive 746 HSR induction; rather, it is the susceptibility of the protein to aggregation combined with high 747 intracellular levels. Lower concentrations of Fluc DM and Fluc WT induced an HSR compared to 748 Htt 72Q and SOD1 G93A and this could suggest that the form of aggregation (i.e. amorphous 749 versus amyloidogenic) may also be an important factor in HSR induction. HSR was more 750 sensitive to increasing levels of Fluc DM and Fluc WT , and/or the induction of the HSR was 751 impaired/evaded by Htt 72Q and SOD1 G93A until a critical concentration was reached. These 752 findings suggest that with increasing saturation of the protein there was an attempt by the cell 753 to restore proteostasis after the accumulation of aggregation-prone proteins by inducing an 754 HSR. Future research could work towards understanding whether the HSR is triggered in 755 response to high concentrations of the soluble aggregation-prone protein or aggregated forms 756 of protein. 757
In summary, this work shows that neurodegenerative disease-associated proteins are poor 758 inducers of the HSR. Extracellular protein aggregates fail to induce the HSR in neuronal-like 759 cells. Most remarkably, the intracellular expression of pathogenic aggregation-prone proteins 760 also has a limited capacity to induce an HSR. Uniquely, we were able to determine the effect 761 of a number of different factors pertaining to protein aggregates on HSR induction, including 762 the aggregation propensity of pathogenic and non-pathogenic proteins, protein concentration 763 within cells, number of inclusions formed, physical properties of the inclusions (size and 764 granularity), and rate at which inclusions formed. Based on flow cytometric and live-cell 765 imaging data it is concluded that HSR induction is dependent on the susceptibility of the 766
